Lyra Historical Income Statement
| LYRA Stock | USD 0.32 0.01 3.03% |
Historical analysis of Lyra Therapeutics income statement accounts such as Interest Expense of 344.2 K can show how well Lyra Therapeutics performed in making a profits. Evaluating Lyra Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Lyra Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Lyra Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lyra Therapeutics is a good buy for the upcoming year.
Lyra |
About Lyra Income Statement Analysis
Lyra Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Lyra Therapeutics shareholders. The income statement also shows Lyra investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Lyra Therapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Lyra Therapeutics. It is also known as Lyra Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Lyra Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Lyra Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyra Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.At present, Lyra Therapeutics' Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 4.3 M, whereas Depreciation And Amortization is forecasted to decline to about 264.1 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 102K | 1.0M | 4.1M | 4.3M | Net Interest Income | 102K | 1.0M | 4.1M | 4.3M |
Lyra Therapeutics income statement Correlations
Click cells to compare fundamentals
Lyra Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lyra Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | 213K | 82K | 102K | 1.0M | 4.1M | 4.3M | |
| Interest Income | 213K | 82K | 102K | 1.0M | 4.1M | 4.3M | |
| Depreciation And Amortization | 27K | 95K | 1.0M | 2.6M | 278K | 264.1K | |
| Interest Expense | 213K | 82K | 102K | 524K | 471.6K | 344.2K | |
| Selling General Administrative | 4.5M | 9.7M | 14.2M | 17.6M | 19.1M | 12.6M | |
| Gross Profit | (27K) | (95K) | 285K | 296K | 1.3M | 1.3M | |
| Other Operating Expenses | 16.5M | 22.2M | 43.9M | 56.4M | 67.1M | 39.3M | |
| Operating Income | (16.5M) | (22.2M) | (43.6M) | (56.3M) | (65.5M) | (62.3M) | |
| Net Income From Continuing Ops | (16.3M) | (22.1M) | (43.5M) | (55.3M) | (61.8M) | (58.7M) | |
| Ebit | (16.5M) | (22.2M) | (43.6M) | (56.3M) | (65.5M) | (62.3M) | |
| Research Development | 12.0M | 12.5M | 29.7M | 38.8M | 47.8M | 26.7M | |
| Ebitda | (16.5M) | (22.1M) | (42.6M) | (53.7M) | (65.3M) | (62.0M) | |
| Total Operating Expenses | 16.5M | 22.2M | 43.9M | 56.4M | 66.8M | 39.3M | |
| Reconciled Depreciation | 27K | 95K | 1.0M | 1.1M | 415K | 492.6K | |
| Income Before Tax | (16.3M) | (22.1M) | (43.5M) | (55.3M) | (62.6M) | (59.5M) | |
| Total Other Income Expense Net | 213K | 82K | 102K | 1.0M | 2.9M | 3.1M | |
| Net Income Applicable To Common Shares | (16.6M) | (22.1M) | (43.5M) | (55.3M) | (49.8M) | (47.3M) | |
| Net Income | (16.1M) | (22.0M) | (42.4M) | (55.3M) | (62.7M) | (59.5M) | |
| Income Tax Expense | (213K) | (82K) | (1.1M) | 13K | 59K | 62.0K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Lyra Stock
When determining whether Lyra Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lyra Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lyra Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lyra Therapeutics Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyra Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyra Therapeutics. If investors know Lyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyra Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share 0.03 | Quarterly Revenue Growth 0.298 | Return On Assets (0.38) | Return On Equity (0.96) |
The market value of Lyra Therapeutics is measured differently than its book value, which is the value of Lyra that is recorded on the company's balance sheet. Investors also form their own opinion of Lyra Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lyra Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyra Therapeutics' market value can be influenced by many factors that don't directly affect Lyra Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyra Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyra Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyra Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.